Cite
The Incidence of Liver Injury in Uyghur Patients Treated for TB in Xinjiang Uyghur Autonomous Region, China, and Its Association with Hepatic Enzyme Polymorphisms NAT2, CYP2E1, GSTM1 and GSTT1.
MLA
Xiang, Yang, et al. “The Incidence of Liver Injury in Uyghur Patients Treated for TB in Xinjiang Uyghur Autonomous Region, China, and Its Association with Hepatic Enzyme Polymorphisms NAT2, CYP2E1, GSTM1 and GSTT1.” PLoS ONE, vol. 9, no. 1, Jan. 2014, pp. 1–8. EBSCOhost, https://doi.org/10.1371/journal.pone.0085905.
APA
Xiang, Y., Ma, L., Wu, W., Liu, W., Li, Y., Zhu, X., Wang, Q., Ma, J., Cao, M., Yao, X., Yang, L., Wubuli, A., Merle, C., Milligan, P., Mao, Y., Gu, J., & Xin, X. (2014). The Incidence of Liver Injury in Uyghur Patients Treated for TB in Xinjiang Uyghur Autonomous Region, China, and Its Association with Hepatic Enzyme Polymorphisms NAT2, CYP2E1, GSTM1 and GSTT1. PLoS ONE, 9(1), 1–8. https://doi.org/10.1371/journal.pone.0085905
Chicago
Xiang, Yang, Long Ma, Weidong Wu, Wei Liu, Yongguang Li, Xia Zhu, Qian Wang, et al. 2014. “The Incidence of Liver Injury in Uyghur Patients Treated for TB in Xinjiang Uyghur Autonomous Region, China, and Its Association with Hepatic Enzyme Polymorphisms NAT2, CYP2E1, GSTM1 and GSTT1.” PLoS ONE 9 (1): 1–8. doi:10.1371/journal.pone.0085905.